AITL is recognized as a CD4 T-cell disorder derived from the malignant transformation of T follicular helper (Tfh) cells, associated with germinal center (GC) B cell dysregulation [2]. The gene discussed is CD4; the disease is angioimmunoblastic T-cell lymphoma.